文献速递心力衰竭与心肌病

射血分数保留的心力衰竭:人类与小鼠模型中的临床复杂性

Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models.
PubMed 文献 · Eur Heart J · 2021-01-01

该综述评估了HFpEF小鼠模型在HFA-PEFF和H2FPEF评分背景下的转化效用,系统记录了每个模型的症状体征、临床特征及心脏内外参数、年龄和性别,发现多数临床前HFpEF模型不符合HFpEF临床标准,尽管某些多因素模型在合理程度上类似人类HFpEF,结论是需要新方法开发临床前模型以优化转化价值。

要点

  • 多数HFpEF小鼠模型不符合HFpEF临床诊断标准
  • 某些多因素模型在合理程度上类似人类HFpEF
  • 需考虑人类HFpEF复杂病理生理开发新临床前模型

核心结论

  • 多数临床前HFpEF模型不符合HFpEF临床标准,尽管某些多因素模型在合理程度上类似人类HFpEF。
  • 为优化小鼠模型对人类HFpEF的转化价值,需要开发考虑人类HFpEF复杂病理生理的新方法。

研究设计与样本

  • 综述,评估HFpEF小鼠模型在HFA-PEFF和H2FPEF评分背景下的转化效用。
  • 系统记录每个HFpEF小鼠模型的HF症状体征或临床HFpEF特征证据,并纳入若干心脏和心外参数以及年龄和性别。

主要发现

  • 多数临床前HFpEF模型不符合HFpEF临床标准。
  • 某些多因素模型在合理程度上类似人类HFpEF。

关键数值与推荐

  • HFpEF临床综合征特征:典型HF体征和症状、独特心脏表型、利钠肽升高。
  • 两种临床算法(HFA-PEFF和H2FPEF评分)已开发用于改进和标准化HFpEF诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heart failure (HF) with preserved ejection fraction (HFpEF) is a multifactorial disease accounting for a large and increasing proportion of all clinical HF presentations. As a clinical syndrome, HFpEF is characterized by typical signs and symptoms of HF, a distinct cardiac phenotype and raised natriuretic peptides. Non-cardiac comorbidities frequently co-exist and contribute to the pathophysiology of HFpEF. To date, no therapy has proven to improve outcomes in HFpEF, with drug development hampered, at least partly, by lack of consensus on appropriate standards for pre-clinical HFpEF models. Recently, two clinical algorithms (HFA-PEFF and H2FPEF scores) have been developed to improve and standardize the diagnosis of HFpEF. In this review, we evaluate the translational utility of HFpEF mouse models in the context of these HFpEF scores. We systematically recorded evidence of symptoms and signs of HF or clinical HFpEF features and included several cardiac and extra-cardiac parameters as well as age and sex for each HFpEF mouse model. We found that most of the pre-clinical HFpEF models do not meet the HFpEF clinical criteria, although some multifactorial models resemble human HFpEF to a reasonable extent. We therefore conclude that to optimize the translational value of mouse models to human HFpEF, a novel approach for the development of pre-clinical HFpEF models is needed, taking into account the complex HFpEF pathophysiology in humans.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Withaar C, Lam CSP, Schiattarella GG, et al. Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models. Eur Heart J. 2021. PMID: 34414416. doi:10.1093/eurheartj/ehab389

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。